Coruña University Hospital / Complexo Hospitalario Universitario A Coruña (CHUAC)

Hospital


Location: A Coruña, Spain (ES) ES

ISNI: 0000 0004 1771 0279

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC (2024) Melchior L, Hirschmann A, Hofman P, Bontoux C, Concha A, Mrabet-Dahbi S, Vannuffel P, et al. Journal article Correction to: Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC (Virchows Archiv, (2024), 10.1007/s00428-024-03778-9) (2024) Melchior L, Hirschmann A, Hofman P, Bontoux C, Concha A, Mrabet‑Dahbi S, Vannuffel P, et al. Journal article, Erratum Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort (2024) Jansen MP, Hodgins D, Mastbergen SC, Kloppenburg M, Blanco FJ, Haugen IK, Berenbaum F, et al. Journal article Quantitative CT of the knee in the IMI-APPROACH osteoarthritis cohort: Association of bone mineral density with radiographic disease severity, meniscal coverage and meniscal extrusion (2023) Heiß R, Laredo JD, Wirth W, Jansen MP, Marijnissen AC, Lafeber F, Lalande A, et al. Journal article Exploring the differences between radiographic joint space width and MRI cartilage thickness changes using data from the IMI-APPROACH cohort (2023) Jansen MP, Roemer F, Marijnissen AKC, Kloppenburg M, Blanco FJ, Haugen IK, Berenbaum F, et al. Journal article Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients (pts) with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant chemotherapy (NACT) (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution PREDICTORS OF LONGITUDINAL MRI-BASED CARTILAGE THICKNESS CHANGE IN THE OBSERVATIONAL MULTICENTER APPROACH COHORT (2022) Maschek S, Roemer F, Marijnissen AC, Jansen M, Wisser A, Lafeber F, Lalande A, et al. Conference contribution Test–retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort (2022) Wirth W, Maschek S, Marijnissen AC, Lalande A, Blanco FJ, Berenbaum F, van de Stadt LA, et al. Journal article